Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,070 | -6,050 | -26,442 | -19,128 | -11,666 |
| Other Working Capital | -1,531 | -2,311 | 4,401 | 2,537 | 1,026 |
| Other Operating Activity | 3,559 | 1,850 | 6,032 | 4,556 | 3,099 |
| Operating Cash Flow | $-11,042 | $-6,511 | $-16,009 | $-12,035 | $-7,541 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,572 | 7 | 31,210 | 30,962 | 17,412 |
| Other Financing Activity | -4 | 0 | -2,100 | -2,018 | -1,611 |
| Financing Cash Flow | $1,568 | $7 | $29,110 | $28,944 | $15,801 |
| Beginning Cash Position | 31,634 | 31,634 | 18,533 | 18,533 | 18,533 |
| End Cash Position | 22,160 | 25,130 | 31,634 | 35,442 | 26,793 |
| Net Cash Flow | $-9,474 | $-6,504 | $13,101 | $16,909 | $8,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,042 | -6,511 | -16,009 | -12,035 | -7,541 |
| Free Cash Flow | -11,042 | -6,511 | -16,009 | -12,035 | -7,541 |